These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
704 related articles for article (PubMed ID: 16388859)
1. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR. Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus. Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436 [TBL] [Abstract][Full Text] [Related]
3. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay. Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227 [TBL] [Abstract][Full Text] [Related]
4. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome. Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520 [TBL] [Abstract][Full Text] [Related]
5. The synergistic effects of betulin with acyclovir against herpes simplex viruses. Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608 [TBL] [Abstract][Full Text] [Related]
7. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239 [TBL] [Abstract][Full Text] [Related]
8. Development of a quantitative real-time TaqMan PCR assay for testing the susceptibility of feline herpesvirus-1 to antiviral compounds. Hussein IT; Field HJ J Virol Methods; 2008 Sep; 152(1-2):85-90. PubMed ID: 18597862 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous titration and phenotypic antiviral drug susceptibility testing for herpes simplex virus 1 and 2. Tardif KD; Jorgensen S; Langer J; Prichard M; Schlaberg R J Clin Virol; 2014 Nov; 61(3):382-6. PubMed ID: 25204613 [TBL] [Abstract][Full Text] [Related]
10. A cell line that secretes inducibly a reporter protein for monitoring herpes simplex virus infection and drug susceptibility. Wang YC; Kao CL; Liu WT; Sun JR; Tai YE; Kung SH J Med Virol; 2002 Dec; 68(4):599-605. PubMed ID: 12376969 [TBL] [Abstract][Full Text] [Related]
11. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir. Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674 [TBL] [Abstract][Full Text] [Related]
12. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro. Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431 [TBL] [Abstract][Full Text] [Related]
13. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity. Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201 [TBL] [Abstract][Full Text] [Related]
14. Rapid susceptibility testing for herpes simplex virus type 1 using real-time PCR. van der Beek MT; Claas EC; van der Blij-de Brouwer CS; Morfin F; Rusman LG; Kroes AC; Vossen AC J Clin Virol; 2013 Jan; 56(1):19-24. PubMed ID: 23026414 [TBL] [Abstract][Full Text] [Related]
15. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus. Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children. Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105 [TBL] [Abstract][Full Text] [Related]
17. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients. Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321 [TBL] [Abstract][Full Text] [Related]
18. Rapid determination of antiviral drug susceptibility of human cytomegalovirus by real-time PCR. Schnepf N; Boiteau N; Petit F; Alain S; Sanson-Le Pors MJ; Mazeron MC Antiviral Res; 2009 Jan; 81(1):64-7. PubMed ID: 18992772 [TBL] [Abstract][Full Text] [Related]
19. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons. Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636 [TBL] [Abstract][Full Text] [Related]
20. Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents. Cotarelo M; Catalán P; Sánchez-Carrillo C; Menasalvas A; Cercenado E; Tenorio A; Bouza E J Antimicrob Chemother; 1999 Nov; 44(5):705-8. PubMed ID: 10552991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]